doi: 10.1126/science.371.6527.329.
New mutations raise specter of 'immune escape'
Affiliations
- PMID:33479129
- DOI: 10.1126/science.371.6527.329
Item in Clipboard
New mutations raise specter of 'immune escape'
Kai Kupferschmidt. Science..
Display options
Format
Display options
Format
No abstract available
Similar articles
- Pfizer COVID vaccine protects against worrying coronavirus variants.Callaway E.Callaway E.Nature. 2021 May;593(7859):325-326. doi: 10.1038/d41586-021-01222-5.Nature. 2021.PMID:33963317No abstract available.
- Coronavirus variants are spreading in India - what scientists know so far.Vaidyanathan G.Vaidyanathan G.Nature. 2021 May;593(7859):321-322. doi: 10.1038/d41586-021-01274-7.Nature. 2021.PMID:33976409No abstract available.
- The great escape? SARS-CoV-2 variants evading neutralizing responses.Prévost J, Finzi A.Prévost J, et al.Cell Host Microbe. 2021 Mar 10;29(3):322-324. doi: 10.1016/j.chom.2021.02.010.Cell Host Microbe. 2021.PMID:33705702Free PMC article.
- Neutralizing SARS-CoV-2.Poeschla E.Poeschla E.Elife. 2020 Dec 15;9:e64496. doi: 10.7554/eLife.64496.Elife. 2020.PMID:33320086Free PMC article.
- Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.Weigang S, Fuchs J, Zimmer G, Schnepf D, Kern L, Beer J, Luxenburger H, Ankerhold J, Falcone V, Kemming J, Hofmann M, Thimme R, Neumann-Haefelin C, Ulferts S, Grosse R, Hornuss D, Tanriver Y, Rieg S, Wagner D, Huzly D, Schwemmle M, Panning M, Kochs G.Weigang S, et al.Nat Commun. 2021 Nov 4;12(1):6405. doi: 10.1038/s41467-021-26602-3.Nat Commun. 2021.PMID:34737266Free PMC article.
Cited by
- Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role.Samuel SM, Varghese E, Büsselberg D.Samuel SM, et al.Trends Microbiol. 2021 Oct;29(10):894-907. doi: 10.1016/j.tim.2021.03.004. Epub 2021 Mar 14.Trends Microbiol. 2021.PMID:33785249Free PMC article.Review.
- Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults.Self WH, Stewart TG, Wheeler AP, El Atrouni W, Bistran-Hall AJ, Casey JD, Cataldo VD, Chappell JD, Cohn CS, Collins JB, Denison MR, de Wit M, Dixon SL, Duggal A, Edwards TL, Fontaine MJ, Ginde AA, Harkins MS, Harrington T, Harris ES, Hoda D, Ipe TS, Jaiswal SJ, Johnson NJ, Jones AE, Laguio-Vila M, Lindsell CJ, Mallada J, Mammen MJ, Metcalf RA, Middleton EA, Mucha S, O'Neal HR Jr, Pannu SR, Pulley JM, Qiao X, Raval JS, Rhoads JP, Schrager H, Shanholtz C, Shapiro NI, Schrantz SJ, Thomsen I, Vermillion KK, Bernard GR, Rice TW; Passive Immunity Trial for Our Nation (PassITON) Investigators.Self WH, et al.Trials. 2021 Mar 20;22(1):221. doi: 10.1186/s13063-021-05171-2.Trials. 2021.PMID:33743799Free PMC article.
- Decision support for the quickest detection of critical COVID-19 phases.Braca P, Gaglione D, Marano S, Millefiori LM, Willett P, Pattipati K.Braca P, et al.Sci Rep. 2021 Apr 20;11(1):8558. doi: 10.1038/s41598-021-86827-6.Sci Rep. 2021.PMID:33879824Free PMC article.
- A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients.Bakacs T, Sandig V, Slavin S, Gumrukcu S, Hardy D, Renz W, Kovesdi I.Bakacs T, et al.Infect Disord Drug Targets. 2022;22(7):1-6. doi: 10.2174/1871526522666220419130403.Infect Disord Drug Targets. 2022.PMID:35440336
- Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures.Ravichandran S, Grubbs G, Tang J, Lee Y, Huang C, Golding H, Khurana S.Ravichandran S, et al.Sci Adv. 2021 Oct 15;7(42):eabi6533. doi: 10.1126/sciadv.abi6533. Epub 2021 Oct 13.Sci Adv. 2021.PMID:34644111Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical